With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for ...

What could go wrong when your feed is flooded with GLP-1 content? A lot.

GLP-1s significantly reduce appetite, slow digestion and promote weight loss.

Some find freedom from food noise. Others face new risks.

Research into how drugs like Wegovy and Zepbound could help people with eating disorders is limited, but emerging.

Premature discontinuation of therapy is one of the most significant challenges in the treatment of eating disorders. Despite the development of effective psychological treatments over recent decades, ...

In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...

Eating disorders affect more than 5% of young people, and they have one of the highest mortality rates of any mental illness. Young patients with public health insurance have a much harder time ...

A pioneering international survey of people living with eating disorders has found that cannabis and psychedelics, such as 'magic mushrooms' or LSD, were best rated as alleviating symptoms by ...

Dozens of eating disorder services are rejecting patients because they are too thin, a damning new report has revealed. The National Audit of Eating Disorders (NAED) found that some inpatient units ...

A US study found that nearly 1 in 3 people with eating disorders had used GLP-1 drugs such as Ozempic, Wegovy or tirzepatide.